Evotec wins $41M R&D contract extension; GSK starts asthma PhIII; Synthetic Biologics raises $10.8M;

Conversation on Twitter :

 @FierceBiotech: Human heart simulated on world's fastest supercomputer. More | Follow @FierceBiotech

 @JohnCFierce: Menarini commits itself to $1B cancer ADC deal with Oxford BioTherapeutics. News | Follow @JohnCFierce

 @RyanMFierce: Five3, maker of cancer genomics software, takes off from UCSC labs. More | Follow @RyanMFierce

> Bayer's Stivarga (regorafenib) gets priority review from FDA for patients with gastrointestinal stromal tumors. News

> Germany's Evotec says that it has extended a research collaboration with the CHDI Foundation, a pact that could be worth up to $41 million in research payments. Release

> GSK ($GSK) says it has launched its Phase III for mepolizumab, an experimental therapy for severe asthma. Release

> Rockville, MD-based Synthetic Biologics has raised $10.8 million in a new financing. Release

> Addex reported positive preclinical data for its experimental therapy aimed at stopping binge drinking. Release

Pharma News

@FiercePharma: Pfizer won't report earnings on Tuesday as planned, thanks to Hurricane Sandy. More | Follow @FiercePharma

> Pfizer reps to bear brunt of Canadian layoffs. Story

> Canada joins in on Novartis vaccine suspension. News

> Docs say they'll wait and see before using biosimilar mAbs. Item

> New AZ chief gets $6.4M to make up for Roche forfeit. Article

Medical Device News

 @FierceMedDev: Hospira faces a Class I recall for its Symbiq infusion system. More | Follow @FierceMedDev

 @MarkHFierce: Drug eluting stents have benefits in people over age 80, acc. to the XIMA study. More | Follow @MarkHFierce

 @DamianFierce: Patheon is spending $255M on softgel specialist Banner Pharmacap. More | Follow @DamianFierce

> Abbott launches massive bond issue to fuel split. Item

> Verax raises $3.3M for blood Dx. News

CRO News

> Patheon buys softgel specialist for $255M. Item

> Small CROs band together to better compete. Story

> Clinipace raises $9M to staff up after acquisition. Article

> Quintiles eyes first global trial for Indonesia. News

Biotech IT News

> Five3, maker of cancer genomics software, takes off from UCSC labs. News

> Human heart simulated on world's fastest supercomputer. Article

> Swedish bioinformatics group grabs $840K to fuel growth, report says. Story

> Accelrys acquisition hunt continues with $30M Aegis deal. Item

And Finally… A regular diet including high levels of flavonoids could reduce a woman's risk of stomach cancer. Story

 

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.